Yuan et al 6. Grotz MR, Ding J, Guo W, Huang Q, Deitch EA. Com- parison of plasma cytokine levels in rats subjected to superior mesenteric artery occlusion or hemorrhagic shock. Shock 1995;3(5):362-368. 7. Heckbert SR, Vedder NB, Hoffman W, Winn RK, Hud- son LD, Jurkovich GJ, Copass MK, et al. Outcome after hemorrhagic shock in trauma patients. J Trauma 1998;45(3):545-549. 8. Antonsson JB, Fiddian-Green RG. The role of the gut in shock and multiple system organ failure. Eur J Surg 1991;157(1):3-12. 9. Xie J, Zeng Q, Wang L. The protective effect of L-carni- tine on ischemia-reperfusion heart. J Huazhong Univ Sci Technolog Med Sci 2006;26(2):188-191. 10. Berni A, Meschini R, Filippi S, Palitti F, De Amicis A, Chessa L. L-carnitine enhances resistance to oxidative stress by reducing DNA damage in Ataxia telangiectasia cells. Mutat Res 2008;650(2):165-174. 11. Oyanagi E, Yano H, Kato Y, Fujita H, Utsumi K, Sasaki J. L-Carnitine suppresses oleic acid-induced membrane permeability transition of mitochondria. Cell Biochem Funct 2008;26(7):778-786. 12. Duchen MR, McGuinness O, Brown LA, Crompton M. On the involvement of a cyclosporin A sensitive mito- chondrial pore in myocardial reperfusion injury. Cardio- vasc Res 1993;27(10):1790-1794. 13. Grifﬁths EJ, Halestrap AP. Protection by Cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts. J Mol Cell Cardiol 1993;25(12):1461-1469. 14. Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN. Intestinal mucosal lesion in low-ﬂow states. I. A mor- phological, hemodynamic, and metabolic reappraisal. Arch Surg 1970;101(4):478-483. 15. Granger DN, Hollwarth ME, Parks DA. Ischemia-reper- fusion injury: role of oxygen-derived free radicals. Acta Physiol Scand Suppl 1986;548:47-63. 16. Yamamoto S, Tanabe M, Wakabayashi G, Shimazu M, Matsumoto K, Kitajima M. The role of tumor ne- crosis factor-alpha and interleukin-1beta in ischemia- reperfusion injury of the rat small intestine. J Surg Res 2001;99(1):134-141. 17. Ceppa EP, Fuh KC, Bulkley GB. Mesenteric hemody- namic response to circulatory shock. Curr Opin Crit Care 2003;9(2):127-132. 18. Carden DL, Granger DN. Pathophysiology of ischaemia- reperfusion injury. J Pathol 2000;190(3):255-266. 19. Park PO, Haglund U, Bulkley GB, Falt K. The sequence of development of intestinal tissue injury after strangula- tion ischemia and reperfusion. Surgery 1990;107(5):574- 580. 20. Penissi AB, Rudolph MI, Piezzi RS. Role of mast cells in gastrointestinal mucosal defense. Biocell 2003;27(2):163-172. 21. Andoh A, Fujiyama Y, Araki Y, Kimura T, Tsujikawa J Clin Med Res • 2011;3(2):78-84 T, Bamba T. Role of complement activation and mast cell degranulation in the pathogenesis of rapid intestinal ischemia/reperfusion injury in rats. Digestion 2001;63 Suppl 1:103-107. 22. Boros M, Ordogh B, Kaszaki J, Nagy S. The role of mast cell degranulation in ischaemia-reperfusion-induced mucosal injury in the small intestine. Ann Acad Med Singapore 1999;28(1):79-84. 23. Ikeda H, Suzuki Y, Suzuki M, Koike M, Tamura J, Tong J, Nomura M, et al. Apoptosis is a major mode of cell death caused by ischaemia and ischaemia/reperfusion in- jury to the rat intestinal epithelium. Gut 1998;42(4):530- 537. 24. Kuenzler KA, Pearson PY, Schwartz MZ. Interleukin-11 enhances intestinal absorptive function after ischemia- reperfusion injury. J Pediatr Surg 2002;37(3):457-459. 25. Prasad R, Alavi K, Schwartz MZ. GLP-2alpha ac- celerates recovery of mucosal absorptive function after intestinal ischemia/reperfusion. J Pediatr Surg 2001;36(4):570-572. 26. Rajeevprasad R, Alavi K, Schwartz MZ. Glucagonlike peptide-2 analogue enhances intestinal mucosal mass and absorptive function after ischemia-reperfusion in- jury. J Pediatr Surg 2000;35(11):1537-1539. 27. Jassem W, Fuggle SV, Rela M, Koo DD, Heaton ND. The role of mitochondria in ischemia/reperfusion injury. Transplantation 2002;73(4):493-499. 28. Tsujimoto Y, Shimizu S. Role of the mitochondrial membrane permeability transition in cell death. Apopto- sis 2007;12(5):835-840. 29. Nazareth W, Yafei N, Crompton M. Inhibition of anox- ia-induced injury in heart myocytes by cyclosporin A. J Mol Cell Cardiol 1991;23(12):1351-1354. 30. Bernardi P, Petronilli V. The permeability transition pore as a mitochondrial calcium release channel: a critical ap- praisal. J Bioenerg Biomembr 1996;28(2):131-138. 31. Piper HM, Meuter K, Schafer C. Cellular mecha- nisms of ischemia-reperfusion injury. Ann Thorac Surg 2003;75(2):S644-648. 32. Di Lisa F, Menabo R, Canton M, Barile M, Bernardi P. Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol Chem 2001;276(4):2571-2575. 33. Grifﬁths EJ, Halestrap AP. Mitochondrial non-speciﬁc pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J 1995;307( Pt 1):93-98. 34. Augustyniak A, Skrzydlewska E. L-Carnitine in the lipid and protein protection against ethanol-induced oxidative stress. Alcohol 2009;43(3):217-223. 35. Virmani A, Gaetani F, Imam S, Binienda Z, Ali S. Possi- ble mechanism for the neuroprotective effects of L-car- nitine on methamphetamine-evoked neurotoxicity. Ann Articles © The authors | Journal compilation © J Clin Med Res and Elmer Press™ | www.jocmr.org 83